Announcing IndieBio SF’s Next Wave – VC-Founder Meetings (June 17 to 21) Learn More

Our hardware is uniquely positioned to efficiently develop and scale the manufacturing of gene-modified cell therapies like chimeric antigen receptor T-cells. Indee Labs powers your research with our patented, non-viral technology to rapidly deliver nucleic acids, proteins, and gene-editing complexes to immune cells while yielding millions to billions of high-quality cells with preserved cell viability and function.